Federal Register / Vol. 76, No. 41 / Wednesday, March 2, 2011 / Notices 11483 

and technological innovation. In 

undertaking these duties, the 

Commission seeks to identify and 

examine specific bioethical, legal, and 

social issues related to potential 

scientific and technological advances; 

examine diverse perspectives and 

possibilities for international 

collaboration on these issues; and 

recommend legal, regulatory, or policy 

actions as appropriate. 

The Commission has begun a review 

of the current rules and standards for 

protecting human subjects in scientific 

studies supported by the Federal 

Government. The President requested 

this study on November 24, 2010, 

following revelations that the U.S. 

Public Health Service supported 

research on sexually transmitted 

diseases in Guatemala from 1946 to 

1948 involving the intentional infection 

of vulnerable populations. President 

Obama asked the Commission Chair ‘‘to 

convene a panel to conduct * * * a 

thorough review of human subjects 

protection to determine if Federal 

regulations and international standards 

adequately guard the health and wellbeing of participants in scientific 

studies supported by the Federal 

Government.’’ 

The President charged the 

Commission to seek the insights and 

perspective of international experts and 

consult with counterparts in the global 

community. The Commission will 

provide the President with a report of its 

findings and recommendations later this 

year. 

To implement this mission, the 

Commission wishes to develop a 

thorough understanding of the current 

U.S. and international standards for 

protecting the health and well-being of 

participants in scientific studies 

supported by the Federal Government. 

To this end, the Commission is inviting 

interested parties to provide input and 

advice through written comments. 

Among other issues, the Commission is 

interested in receiving comments on the 

existing standards for protecting human 

subjects, both domestically and 

internationally; how the current system 

of global research works in practice; and 

the ethical and social justice issues that 

emerge from the current research 

system. Comments concerning the 

benefits of medical research; differences 

across global norms and standards; 

standards for ancillary care and posttrial access to treatment; trial design; 

duties to participants; challenges, if any, 

faced by U.S.-funded researchers 

working internationally, or international 

researchers collaborating on U.S.- 

funded research; and other specific 

information are all especially welcome. 

The Commission is under a very tight 

deadline and would appreciate 

comments within 60 days. 

Please address comments by e-mail to 

info@bioethics.gov, or by mail to the 

following address: Public Commentary, 

The Presidential Commission for the 

Study of Bioethical Issues, 1425 New 

York Ave. NW., Suite C–100, 

Washington, DC 20005. Comments will 

be publicly available, including any 

personally identifiable or confidential 

business information that they contain. 

Trade secrets should not be submitted. 

Dated: February 17, 2011. 

Valerie H. Bonham, 

Executive Director, The Presidential 

Commission for the Study of Bioethical Issues. 

[FR Doc. 2011–4658 Filed 3–1–11; 8:45 am] 

BILLING CODE 4154–06–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Subcommittee on Procedures Review, 

Advisory Board on Radiation and 

Worker Health (ABRWH), National 

Institute for Occupational Safety and 

Health (NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting for the 

aforementioned subcommittee: 

Time and Date: 9 a.m.–5 p.m., March 

22, 2011. 

Place: Cincinnati Airport Marriott, 

2395 Progress Drive, Hebron, KY 41018. 

Telephone (859) 334–4611, Fax (859) 

334–4619. 

Status: Open to the public, but 

without a public comment period. To 

access by conference call dial the 

following information: (866) 659–0537, 

Participant Pass Code 9933701. 

Background: The ABRWH was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

compensation program. Key functions of 

the ABRWH include providing advice 

on the development of probability of 

causation guidelines that have been 

promulgated by the Department of 

Health and Human Services (HHS) as a 

final rule; advice on methods of dose 

reconstruction which have also been 

promulgated by HHS as a final rule; 

advice on the scientific validity and 

quality of dose estimation and 

reconstruction efforts being performed 

for purposes of the compensation 

program; and advice on petitions to add 

classes of workers to the Special 

Exposure Cohort (SEC). 

In December 2000, the President 

delegated responsibility for funding, 

staffing, and operating the ABRWH to 

HHS, which subsequently delegated this 

authority to CDC. NIOSH implements 

this responsibility for CDC. The charter 

was issued on August 3, 2001, renewed 

at appropriate intervals, and will expire 

on August 3, 2011. 

Purpose: The ABRWH is charged with 

(a) Providing advice to the Secretary, 

HHS, on the development of guidelines 

under Executive Order 13179; (b) 

providing advice to the Secretary, HHS, 

on the scientific validity and quality of 

dose reconstruction efforts performed 

for this program; and (c) upon request 

by the Secretary, HHS, advising the 

Secretary on whether there is a class of 

employees at any Department of Energy 

facility who were exposed to radiation 

but for whom it is not feasible to 

estimate their radiation dose, and on 

whether there is a reasonable likelihood 

that such radiation doses may have 

endangered the health of members of 

this class. The Subcommittee on 

Procedures Review was established to 

aid the ABRWH in carrying out its duty 

to advise the Secretary, HHS, on dose 

reconstructions. The Subcommittee on 

Procedures Review is responsible for 

overseeing, tracking, and participating 

in the reviews of all procedures used in 

the dose reconstruction process by the 

NIOSH Division of Compensation 

Analysis and Support (DCAS) and its 

dose reconstruction contractor. 

Matters to be Discussed: The agenda 

for the Subcommittee meeting includes 

discussion of the following ORAU and 

OCAS procedures: ORAUT–RPRT–0044 

(‘‘Analysis of Bioassay Data with a 

Significant Fraction of Less-Than 

Results’’), OCAS TIB–0013 (‘‘Special 

External Dose Reconstruction 

Considerations for Mallinckrodt 

Workers’’), OTIB–014 (‘‘Rocky Flats 

Internal Dosimetry Co-Worker 

Extension’’), OTIB–019 (‘‘Analysis of 

Coworker Bioassay Data for Internal 

Dose Assignment’’), OTIB–0029 

(‘‘Internal Dosimetry Coworker Data for 

Y–12’’), OTIB–0047 (‘‘External Radiation 

Monitoring at the Y–12 Facility During 

the 1948–1949 Period’’), OTIB–0049 

(‘‘Estimating Doses for Plutonium 

Strongly Retained in the Lung’’), OTIB– 

0052 (‘‘Parameters to Consider When 

Processing Claims for Construction 

Trade Workers’’), OTIB–0054 (‘‘Fission 

and Activation Product Assignment for 

Internal Dose-Related Gross Beta and 

Gross Gamma Analyses’’), and OTIB– 


emcdonald on DSK2BSOYB1PROD with NOTICES
11484 Federal Register / Vol. 76, No. 41 / Wednesday, March 2, 2011 / Notices 

0070 (‘‘Dose Reconstruction During 

Residual Radioactivity Periods at 

Atomic Weapons Employer Facilities’’); 

and a continuation of the commentresolution process for other dose 

reconstruction procedures under review 

by the Subcommittee. 

The agenda is subject to change as 

priorities dictate. 

This meeting is open to the public, 

but without a public comment period. 

In the event an individual wishes to 

provide comments, written comments 

may be submitted. Any written 

comments received will be provided at 

the meeting and should be submitted to 

the contact person below in advance of 

the meeting. 

Contact Person for More Information: 

Theodore Katz, Executive Secretary, 

NIOSH, CDC, 1600 Clifton Road, 

Mailstop E–20, Atlanta, GA 30333, 

Telephone (513) 533–6800, Toll Free 1 

(800) CDC–INFO, E-mail dcas@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention, and the Agency for Toxic 

Substances and Disease Registry. 

Dated: February 24, 2011. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2011–4597 Filed 3–1–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–9978–N2] 

Public Meeting of the Consumer 

Operated and Oriented Plan (CO–OP) 

Advisory Board, March 14, 2011 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces the 

third meeting of an advisory committee 

to the Center for Consumer Information 

and Insurance Oversight (CCIIO) in 

accordance with the Federal Advisory 

Committee Act. The meeting is open to 

the public. The purpose of the meeting 

is to assist and advise the Secretary and 

the Congress on the Department’s 

strategy to foster the creation of 

qualified nonprofit health insurance 

issuers. Specifically, the Committee 

shall advise the Secretary and the 

Congress concerning the award of grants 

and loans related to Section 1322 of the 

Affordable Care Act, which provides for 

a Federal program to assist 

establishment and operation of 

nonprofit, member run health insurance 

issuers. In these matters, the Committee 

shall consult with all components of the 

Department, other federal entities, and 

non-Federal organizations, as 

appropriate; and examine relevant data 

sources to assess the grant and loan 

award strategy to provide 

recommendations to CCIIO. 

DATES: Meeting Date: March 14, 2011 

from 8:30 a.m. to 5 p.m., Eastern 

Standard Time (EST) Deadline for 

Meeting Registration, Presentations and 

Comments: March 10, 2011, 5 p.m., 

EST. Deadline for Requesting Special 

Accommodations: March 10, 2011, 5 

p.m., EST. 

ADDRESSES: Meeting Location: Madison 

Hotel, 1177 15th Street, NW., 

Washington, DC 20005. 

Meeting Online Access: To participate 

in this meeting via the Internet, go to 

http://www.readyshow.com/ and enter 

participant code 49888151. Note that 

audio of the meeting will only be 

broadcast through the conference phone 

line. 

Meeting Phone Access: To participate 

in this meeting via phone, please dial 

into the toll free phone number 1–888– 

299–4099, and provide the following 

code to the operator: VW38426. 

Meeting Registration, Presentations, 

and Written Comments: Anne Bollinger, 

Center for Consumer Information and 

Insurance Oversight, CMS, 200 

Independence Avenue, SW., 

Washington, DC 20201, 301–492–395, 

Fax: 301–492–4462, or contact by e-mail 

at anne.bollinger@hhs.gov. Written 

comments must be submitted in Word 

format. 

Registration: The meeting is open to 

the public, but attendance is limited to 

the space available. Persons wishing to 

attend this meeting must register by 

contacting the designated Federal 

official at the address listed in the 

ADDRESSES section of this notice or by 

telephone at the number listed in the 

FOR FURTHER INFORMATION CONTACT

section of this notice, by the date listed 

in the DATES section of this notice. 

FOR FURTHER INFORMATION CONTACT: 

Anne Bollinger, 301–492–4395. Press 

inquiries are handled through CCIIO’s 

Press Office at (202) 690–6343. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The purpose of the meeting is to assist 

and advise the Secretary and the 

Congress on the Department’s strategy to 

foster the creation of qualified nonprofit 

health insurance issuers. Specifically, 

the Committee shall advise the 

Secretary and the Congress concerning 

the award of grants and loans related to 

section 1322 of the Affordable Care Act, 

which provides for a Federal program to 

assist establishment and operation of 

nonprofit, member run health insurance 

issuers. In these matters, the Committee 

shall consult with all components of the 

Department, other Federal entities, and 

non-Federal organizations, as 

appropriate; and examine relevant data 

sources to assess the grant and loan 

award strategy to provide 

recommendations to CCIIO. 

II. Meeting Agenda 

The Committee will hear comments 

from the public and then begin 

deliberations on proposed 

recommendations presented by the 

work groups from the Committee. CCIIO 

intends to make background material 

available to the public no later than two 

(2) business days prior to the meeting. 

If CCIIO is unable to post the 

background material on its Web site 

prior to the meeting, it will be made 

publicly available at the location of the 

advisory committee meeting, and the 

background material will be posted on 

CCIIO’s Web site after the meeting, at 

http://hhs.gov/CCIIO. 

Oral comments from the public will 

be scheduled between approximately 

8:30 a.m.–9:30 a.m. Individuals or 

organizations that wish to make a 3- 

minute oral presentation on an agenda 

topic should submit a written copy in 

Word format of the oral presentation to 

the designated federal official (DFO) at 

the address listed in the ADDRESSES

section of this notice by the date listed 

in the DATES section of this notice. The 

number of oral presentations may be 

limited by the time available. Persons 

attending CCIIO’s advisory committee 

meetings are advised that the agency is 

not responsible for providing access to 

electrical outlets. If the number of 

speakers requesting to comment is 

greater than can be reasonably 

accommodated during the scheduled 

open public comment session, CCIIO 

will take written comments after the 

meeting until close of business. 

Individuals not wishing to make a 

presentation may submit written 

comments in Word format to the DFO at 

the address listed in the ADDRESSES

section of this notice by the date listed 

in the DATES section of this notice. 

Individuals requiring sign language 

interpretation or other special 

accommodations must contact the DFO 

via the contact information specified in 


emcdonald on DSK2BSOYB1PROD with NOTICES